Immunoperoxidase detection of Yellow Fever virus after natural and experimental infections
- PMID: 6359596
Immunoperoxidase detection of Yellow Fever virus after natural and experimental infections
Abstract
Accurate diagnosis of fatal Yellow Fever (YF) is important for surveillance and prevention of epidemics in regions where the virus is endemic. Immunoperoxidase (IP) staining for viral antigens offers a means to both document infection and investigate pathogenic mechanisms. We developed an indirect IP staining assay for YF, which was used to detect YF antigen in histologic sections of human liver from patients with fatal natural infections, and suckling mouse brains experimentally inoculated with an unattenuated neurotropic strain of YF virus. In human liver, specific IP staining was present in the cytoplasm of hepatocytes, but in mouse brain, specific IP staining was localized within nuclei of neurons. The distribution of IP staining corresponded to the location of degenerative morphologic changes within cells; however, IP staining was more widespread than expected on the basis of histopathologic lesions. Furthermore, the degree of inflammation was disproportionately mild compared to the extent of infection, i.e. distribution of YF antigen, both in human liver and suckling mouse brain. The results suggest that the pathogenesis of YF in humans and suckling mice is overwhelming viral infection with minimal associated host immunological and/or inflammatory response in tissues.
Similar articles
-
Immunoperoxidase staining for detection of Colorado tick fever virus, and a study of congenital infection in the mouse.Am J Trop Med Hyg. 1979 Jul;28(4):729-32. Am J Trop Med Hyg. 1979. PMID: 223460
-
[Integrated approach to yellow fever surveillance: pilot study in Senegal in 2003-2004].Bull Soc Pathol Exot. 2007 Aug;100(3):187-92. Bull Soc Pathol Exot. 2007. PMID: 17824313 French.
-
Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology.J Infect Dis. 2001 May 15;183(10):1437-44. doi: 10.1086/320200. Epub 2001 Apr 17. J Infect Dis. 2001. PMID: 11319680
-
Treatment of yellow fever.Antiviral Res. 2008 Apr;78(1):116-24. doi: 10.1016/j.antiviral.2007.10.009. Epub 2007 Nov 20. Antiviral Res. 2008. PMID: 18061688 Review.
-
Prevention of yellow fever in persons traveling to the tropics.Clin Infect Dis. 2002 May 15;34(10):1369-78. doi: 10.1086/340104. Epub 2002 Apr 25. Clin Infect Dis. 2002. PMID: 11981733 Review.
Cited by
-
Present status of yellow fever: memorandum from a PAHO meeting.Bull World Health Organ. 1986;64(4):511-24. Bull World Health Organ. 1986. PMID: 3490922 Free PMC article.
-
Astrocytic reaction predominance in chronic encephalitis of Junin virus-infected rats.J Med Virol. 1989 Dec;29(4):327-33. doi: 10.1002/jmv.1890290420. J Med Virol. 1989. PMID: 2559956 Free PMC article.